When initiating tirzepatide, consideration should be given to reducing the dose of concomitantly administered insulin secretagogues (such as sulfonylureas) or insulin to lower the risk of hypoglycemia. Tirzepatide delays gastric emptying and may therefore affect the absorption of concomitantly administered oral medications, so caution should be exercised during use.